Quick Takeaways
- Francis M. Cuss has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $28,348.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Francis M. Cuss
- Location
- Princeton, NJ
- Summary
- The estimated net worth of Francis M. Cuss is at least $28,348 dollars as of 05 Dec 2025. Francis M. Cuss is the Director of Mural Oncology plc and owns shares of Mural Oncology plc stock worth about $28.3K.
- Signature
- /s/ Francis M. Cuss
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Francis M. Cuss and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Mural Oncology plc ($28,348).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Francis M. Cuss
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MURA | Mural Oncology plc | Director | $28,348 | 05 Dec 2025 | ||
| RUBY | Rubius Therapeutics, Inc. | Director | 12 May 2022 |
Insider Transactions Reported by Francis M. Cuss:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.